Syra Health ROE 2022-2025 | SYRA
Current and historical return on equity (ROE) values for Syra Health (SYRA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Syra Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $0.00B | $0.00B | -80.00% |
| 2024-12-31 | $0.00B | $0.00B | -109.09% |
| 2024-09-30 | $0.00B | $0.00B | -100.00% |
| 2024-06-30 | $0.00B | $0.00B | -150.00% |
| 2024-03-31 | $0.00B | $0.00B | -200.00% |
| 2023-12-31 | $0.00B | $0.00B | -400.00% |
| 2023-06-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.001B | $0.008B |
| Syra Health Corp. is a healthcare technology company. It offers products and services in digital health, behavioral and mental health, population health management, health education and healthcare workforce. Syra Health Corp. is based in CARMEL, Ind. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.988B | 53.85 |
| Hims & Hers Health (HIMS) | United States | $13.954B | 144.98 |
| Tempus AI (TEM) | United States | $10.977B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.526B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.418B | 69.02 |
| Privia Health (PRVA) | United States | $3.048B | 208.33 |
| Enovis (ENOV) | United States | $2.027B | 11.30 |
| Clover Health Investments (CLOV) | United States | $1.832B | 0.00 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Phreesia (PHR) | United States | $1.510B | 0.00 |
| Omnicell (OMCL) | United States | $1.305B | 23.02 |
| Azenta (AZTA) | United States | $1.242B | 57.70 |
| 10x Genomics (TXG) | United States | $1.100B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.646B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.574B | 0.00 |
| Talkspace (TALK) | United States | $0.504B | 150.50 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Claritev (CTEV) | United States | $0.452B | 0.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.376B | 834.00 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.231B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.144B | 0.00 |
| Pulmonx (LUNG) | United States | $0.134B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| Outset Medical (OM) | United States | $0.070B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.041B | 0.00 |
| Zhongchao (ZCMD) | China | $0.032B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
| Precipio (PRPO) | United States | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |